T

Thalia Therapeutics

HealthUnited Kingdom

Thalia Therapeutics is a UK-based biotechnology company specializing in RNA-based medical solutions. The company has raised €3.1 million to accelerate its clinical-stage oncology and RNA-based pipeline, including the acquisition of Sanmirna Therapeutics, which brings a microRNA therapeutic candidate into its portfolio.

$3.3MVisit website ↗

Funding history

  1. $3.3M2026-06-28
    Source: news.google.com ↗

Founder

D
Dr. David Solomon
CEO

Investors in Thalia Therapeutics

Backers from this company's tracked funding rounds.

  • Premier Miton

More Health companies

Recently funded startups in the same category.

Related on Datapile